LawrencePeterLeichmanMD

PubMed

• 44 citations
  Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial.
  Howard P Safran, Kathryn Winter, David H Ilson, Dennis Wigle, Thomas DiPetrillo, Michael G Haddock, Theodore S Hong, Lawrence P Leichman, Lakshmi Rajdev, Murray Resnic...> ;The Lancet. Oncology. 2022 Feb 1
• Going Back.
  Lawrence Leichman> ;The Oncologist. 2021 Jan 1
• 6 citations
  Phase II Study of Preoperative Chemoradiotherapy with Oxaliplatin, Infusional 5-Fluorouracil, and Cetuximab Followed by Postoperative Docetaxel and Cetuximab in Patien...
  M. K. Gibson, Paul J. Catalano, Lawrence Kleinberg, Charles A. Staley, Elizabeth A. Montgomery, Antonio Jimeno, Wei Frank Song, Mary F. Mulcahy, Lawrence Leichman, Al ...> ;The Oncologist. 2020 Jan 1
• 3 citations
  Evaluation of treatment and outcomes for Hispanic patients with gastric cancer at Commission on Cancer‐accredited centers in the United States
  Beiqun Zhao, Lawrence Leichman, Santiago Horgan, Michael Bouvet, Kaitlyn J. Kelly> ;Journal of Surgical Oncology. 2019 Jun 1
• 37 citations
  Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival
  Shumei Kato, Maria Schwaederle, Paul T. Fanta, Ryosuke Okamura, Lawrence Leichman, Scott M. Lippman, Richard B. Lanman, Victoria M. Raymond, AmirAli Talasaz, Razelle K...> ;JCO Precision Oncology. 2019 Jan 25
• 18 citations
  Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics.
  In Sil Choi, Shumei Kato, Paul T. Fanta, Lawrence Leichman, Ryosuke Okamura, Victoria M. Raymond, Richard B. Lanman, Scott M. Lippman, Razelle Kurzrock> ;Molecular Cancer Therapeutics. 2019 Jan 1
• 73 citations
  Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma.
  Shumei Kato, Ryosuke Okamura, Joel M. Baumgartner, Hitendra Patel, Lawrence Leichman, Kaitlyn J. Kelly, Jason K. Sicklick, Paul T. Fanta, Scott M. Lippman, Razelle Kur...> ;Clinical Cancer Research. 2018 Dec 15
• 23 citations
  Impact of socioeconomic status on survival for patients with anal cancer
  Daniel Lin, Heather T. Gold, David Schreiber, Lawrence Leichman, Scott E. Sherman, Daniel J. Becker> ;Cancer. 2018 Apr 15
• 1 citations
  Delivery of adjuvant chemotherapy among stage III colon cancer patients at a public versus private hospital in New York City.
  Daniel Lin, Judith D. Goldberg, Tsivia Hochman, Benjamin Levinson, Maria R. Khan, Elliot Newman, Lawrence Leichman, Heather T. Gold> ;Cancer Causes & Control. 2018 Feb 1
• 46 citations
  Immunotherapy in pancreatic cancer: Unleash its potential through novel combinations
  Songchuan Guo, Merly Contratto, George Miller, Lawrence Leichman, Jennifer Wu> ;World Journal of Clinical Oncology. 2017 Jun 10
• 11 citations
  A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology...
  Steven J. Cohen, Bert H. O'Neil, Jordan Berlin, Patricia Ames, Marti McKinley, Julie Horan, Patricia M. Catalano, Angela M. Davies, Colin D. Weekes, Lawrence Leichman> ;Cancer Chemotherapy and Pharmacology. 2016 Feb 17
• 54 citations
  Phase II Study of Olaparib (AZD-2281) After Standard Systemic Therapies for Disseminated Colorectal Cancer
  Lawrence Leichman, Susan Groshen, Bert H. O'Neil, Wells A. Messersmith, Jordan Berlin, Emily Chan, Cynthia G. Leichman, Steven J. Cohen, Deirdre Jill Cohen, Heinz-Jose...> ;The Oncologist. 2016 Feb 1
• 19 citations
  A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...
  Bert H. O'Neil, A. J. Scott, W. W. Ma, Steven J. Cohen, Lawrence Leichman, Dara L. Aisner, Alex R. Menter, Mohamedtaki Abdulaziz Tejani, Jonathan K. Cho, J. Granfortun...> ;Annals of Oncology. 2015 Dec 1
• 26 citations
  HIV Infection Is Associated With Poor Outcomes for Patients With Anal Cancer in the Highly Active Antiretroviral Therapy Era.
  D. Grew, Danielle S. Bitterman, Cynthia G. Leichman, Lawrence Leichman, Nicholas J. Sanfilippo, Harvey G. Moore, K.L. Du> ;Diseases of the Colon and Rectum. 2015 Dec 1
• A phase II/III randomized study to compare the efficacy and safety of rigosertib plus gemcitabine versus gemcitabine alone in patients with previously untreated metast...
  O'Neil BH, Scott AJ, Ma WW, Cohen SJ, Leichman L, Aisner DL, Menter AR, Tejani MA, Cho JK, Granfortuna J, Coveler L, Olowokure OO, Baranda JC, Cusnir M, Phillip P, Bol...> ;Ann. Oncol.. 2015-09-01
• 10 citations
  Comparison of anal cancer outcomes in public and private hospital patients treated at a single radiation oncology center.
  Danielle S. Bitterman, D. Grew, Ping Gu, Richard F. Cohen, Nicholas J. Sanfilippo, Cynthia G. Leichman, Lawrence Leichman, Harvey G. Moore, Heather T. Gold, K.L. Du> ;Journal of Gastrointestinal Oncology. 2015 May 19
• 62 citations
  Controversies in the Treatment of Local and Locally Advanced Gastric and Esophageal Cancers
  Deirdre Jill Cohen, Lawrence Leichman> ;Journal of Clinical Oncology. 2015 Apr 27
• 10 citations
  The current status of neoadjuvant therapy for esophageal cancer.
  Daniel Lin, Lawrence Leichman> ;Seminars in Thoracic and Cardiovascular Surgery. 2014 Jun 1
• Erratum to: Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer.
  Hochster, H. S.,Uboha, N.,Messersmith, W.,Gold, P. J.,ONeil, B. H.,Cohen, D.,Denlinger, C.,Cohen, S.,Leichman, C. G.,Leichman, L.,Lenz, H. J.> ;Cancer Chemother. Pharmacol.. 2014 Dec 03
• 25 citations
  Phase II study of selumetinib (AZD6244, ARRY-142886) plus irinotecan as second-line therapy in patients with K-RAS mutated colorectal cancer
  Howard S. Hochster, N. Uboha, Wells A. Messersmith, Philip J. Gold, Bert H. O'Neil, Deirdre Jill Cohen, Crystal S. Denlinger, Steven J. Cohen, C. G. Leichman, L Leichm...> ;Cancer Chemotherapy and Pharmacology. 2015 Jan 1
• NO147: The Giving Tree
  Lawrence Leichman> ;Journal of the National Cancer Institute. 2014 Jul 1
• 22 citations
  Chemoradiation Therapy versus Chemotherapy Alone for Gastric Cancer after R0 Surgical Resection: A Meta-Analysis of Randomized Trials
  C. Min, Sripal Bangalore, Sachin R. Jhawar, Yu Guo, Joseph Nicholson, Silvia C. Formenti, Lawrence Leichman, K.L. Du> ;Oncology. 2014 Jan 15
• 11 citations
  Safety and pharmacokinetics of high-dose gefitinib in patients with solid tumors: results of a phase I study
  Mitchell E. Gross, Lawrence Leichman, Elizabeth S. Lowe, Alan Swaisland, David B. Agus> ;Cancer Chemotherapy and Pharmacology. 2012 Jan 1
• 49 citations
  S0356: A Phase II Clinical and Prospective Molecular Trial With Oxaliplatin, Fluorouracil, and External-Beam Radiation Therapy Before Surgery for Patients With Esophag...
  Lawrence Leichman, Bryan Goldman, Pierre Oliver Bohanes, Heinz Joseph Lenz, Charles R. Thomas, Kevin G. Billingsley, Christopher L. Corless, Syma Iqbal, Philip J. Gold...> ;Journal of Clinical Oncology. 2011 Dec 1
• 67 citations
  Pharmacokinetic dose-scheduling study of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with locally-advanced or metastatic solid tumors
  Patricia LoRusso, Antonio Jimeno, Grace K. Dy, Alex A. Adjei, Jordan Berlin, Lawrence Leichman, Jennifer A. Low, Dawn Colburn, Ilsung Chang, Sravanthi Cheeti, Jin Y. J...> ;Clinical Cancer Research. 2011 Sep 1
• Join now to see all

Journal Articles

• Analysis of Circulating Tumor DNA and Clinical Correlates in Patients with Esophageal, Gastroesophageal Junction and Gastric Adenocarcinoma  
  Lawrence Leichman, Jason K Sicklick, Shumei Kato, Kaitlyn Kelly, Scott M Lippman, Clinical Cancer Research